Literature DB >> 27157728

In vitro degradation of ZM21 magnesium alloy in simulated body fluids.

Agnieszka Witecka1, Aleksandra Bogucka2, Akiko Yamamoto3, Kristián Máthis4, Tomáš Krajňák4, Jakub Jaroszewicz2, Wojciech Święszkowski2.   

Abstract

In vitro degradation behavior of squeeze cast (CAST) and equal channel angular pressed (ECAP) ZM21 magnesium alloy (2.0wt% Zn-0.98wt% Mn) was studied using immersion tests up to 4w in three different biological environments. Hanks' Balanced Salt Solution (Hanks), Earle's Balanced Salt Solution (Earle) and Eagle minimum essential medium supplemented with 10% (v/v) fetal bovine serum (E-MEM+10% FBS) were used to investigate the effect of carbonate buffer system, organic compounds and material processing on the degradation behavior of the ZM21 alloy samples. Corrosion rate of the samples was evaluated by their Mg(2+) ion release, weight loss and volume loss. In the first 24h, the corrosion rate sequence of the CAST samples was as following: Hanks>E-MEM+10% FBS>Earle. However, in longer immersion periods, the corrosion rate sequence was Earle>E-MEM+10% FBS≥Hanks. Strong buffering effect provided by carbonate buffer system helped to maintain the pH avoiding drastic increase of the corrosion rate of ZM21 in the initial stage of immersion. Organic compounds also contributed to maintain the pH of the fluid. Moreover, they adsorbed on the sample surface and formed an additional barrier on the insoluble salt layer, which was effective to retard the corrosion of CAST samples. In case of ECAP, however, this effect was overcome by the occurrence of strong localized corrosion due to the lower pH of the medium. Corrosion of ECAP samples was much greater than that of CAST, especially in Hanks, due to higher sensitivity of ECAP to localized corrosion and the presence of Cl(-). The present work demonstrates the importance of using an appropriate solution for a reliable estimation of the degradation rate of Mg-base degradable implants in biological environments, and concludes that the most appropriate solution for this purpose is E-MEM+10% FBS, which has the closest chemical composition to human blood plasma.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ECAP; In vitro degradation; Simulated body fluids; ZM21 magnesium alloy

Mesh:

Substances:

Year:  2016        PMID: 27157728     DOI: 10.1016/j.msec.2016.04.019

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

1.  Biological Assessment of Zn-Based Absorbable Metals for Ureteral Stent Applications.

Authors:  Devi Paramitha; Stéphane Chabaud; Stéphane Bolduc; Hendra Hermawan
Journal:  Materials (Basel)       Date:  2019-10-12       Impact factor: 3.623

2.  Controlling the Degradation Rate of Biodegradable Mg-Zn-Mn Alloys for Orthopedic Applications by Electrophoretic Deposition of Hydroxyapatite Coating.

Authors:  Iulian Antoniac; Florin Miculescu; Cosmin Cotrut; Anton Ficai; Julietta V Rau; Elena Grosu; Aurora Antoniac; Camelia Tecu; Ioan Cristescu
Journal:  Materials (Basel)       Date:  2020-01-07       Impact factor: 3.623

3.  In Vivo Simulation of Magnesium Degradability Using a New Fluid Dynamic Bench Testing Approach.

Authors:  Ole Jung; Dario Porchetta; Marie-Luise Schroeder; Martin Klein; Nils Wegner; Frank Walther; Frank Feyerabend; Mike Barbeck; Alexander Kopp
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

4.  In Vitro Degradation Behaviors of Manganese-Calcium Phosphate Coatings on an Mg-Ca-Zn Alloy.

Authors:  Yichang Su; Yingchao Su; Wei Zai; Guangyu Li; Cuie Wen
Journal:  Scanning       Date:  2018-02-13       Impact factor: 1.932

5.  Bio-corrosion impacts on mechanical integrity of ZM21 Mg for orthopaedic implant application processed by equal channel angular pressing.

Authors:  S Prithivirajan; Mayur Bapu Nyahale; Gajanan M Naik; S Narendranath; Ashwini Prabhu; P D Rekha
Journal:  J Mater Sci Mater Med       Date:  2021-06-12       Impact factor: 3.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.